Tamoxifen increases methamphetamine-evoked dopamine output from superfused striatal tissue fragments of male mice

Brain Research

Volumn 1029, Issue 2, 2004, Pages 186-194

  Willett, Matthew C ^a   Dluzen, Dean E ^a  

^a NORTHEAST OHIO MEDICAL UNIVERSITY   (United States)

Author keywords

Antiestrogen; Estrogen; Neuroprotection; Neurotoxicity; Nigrostriatal; Parkinson's disease

Indexed keywords

DOPAMINE TRANSPORTER; METHAMPHETAMINE; POTASSIUM CHLORIDE; TAMOXIFEN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE RELEASE; DOPAMINERGIC SYSTEM; DOSE RESPONSE; DRUG EFFECT; MALE; MOUSE; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

ANIMALS; CORPUS STRIATUM; DOPAMINE; DOPAMINE AGENTS; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; DRUG SYNERGISM; ESTROGEN ANTAGONISTS; MALE; MEMBRANE GLYCOPROTEINS; MEMBRANE TRANSPORT PROTEINS; METHAMPHETAMINE; MICE; MICE, INBRED STRAINS; NERVE TISSUE PROTEINS; TAMOXIFEN;

EID: 7944228497     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.brainres.2004.09.043     Document Type: Article

References (50)

1. M.C. Allen, C. Newland, M.A. Valverde, and S.P. Hardy Inhibition of ligand-gated cation-selective channels by tamoxifen Eur. J. Pharmacol. 354 1998 261 269
2. M.C. Allen, P.A. Gale, A.C. Hunter, A. Lloyd, and S.P. Hardy Membrane impermeant antioestrogens discriminate between ligand- and voltage-gated cation channels in NG108-15 cells Biochim. Biophys. Acta 1509 2000 229 236
3. S.N. Baksi, M.J. Hughes, and K.E. Light Alterations of dopamine metabolism in different brain regions of the rabbit by estradiol and tamoxifen Neuroscience 14 1985 1053 1059
4. K.B. Burrows, W.L. Nixdorf, and B.K. Yamamoto Central administration of methamphetamine synergizes with metabolic inhibition to deplete striatal monoamines J. Pharmacol. Exp. Ther. 292 2000 853 860
5. M.C. Cabot, Z.C. Zhang, and A.E. Guiliano Tamoxifen elicits rapid transmembrane ligand signal responses in human breast cancer cells Breast Cancer Res. Treat. 36 1995 299 306
6. C.S. Chaurasia, C.E. Chen, J. Rubin, and S.L. Dewey Effects of tamoxifen on striatal dopamine and 5-hydroxytryptamine release in freely moving male rats: an in vivo microdialysis investigation J. Pharm. Pharmacol. 50 1998 1377 1385
7. M. Cyr, F. Calon, M. Morissette, M. Grandbois, S. Callier, and T. Di Paolo Drugs with estrogen-like potency and brain activity: potential therapeutic application for the CNS Curr. Pharm. Des. 6 2000 1287 1312
8. M. Cyr, C. Thibault, M. Morissette, M. Landry, and T. Di Paolo Estrogen-like activity of tamoxifen and raloxifene on NMDA receptor binding and expression of its subunits in rat brain Neuropsychopharmacology 25 2001 242 257
9. A. Dicko, M. Morissette, S. Ben Ameur, M. Pezolet, and T. Di Paolo The effect of estradiol and tamoxifen on brain membranes: investigation by infrared and fluorescence spectroscopy Brain Res. Bull. 49 1999 401 405
10. K.A. Disshon, and D.E. Dluzen Use of in vitro superfusion to assess the dynamics of striatal dopamine clearance: influence of estrogen Brain Res. 842 1999 399 407
11. D.E. Dluzen Neuroprotective effects of estrogen upon the nigrostriatal dopaminergic system J. Neurocytol. 29 2000 387 399
12. D.E. Dluzen, and L.I. Anderson The effect of nicotine on dopamine and DOPAC output from rat striatal tissue Eur. J. Pharmacol. 341 1998 23 32
13. D.E. Dluzen, and M.W.I.M. Horstink Estrogen as a neuroprotectant of nigrostriatal dopaminergic system Endocrine 21 2003 67 75
14. D.E. Dluzen, and J.L. McDermott Estrogen, anti-estrogen, and gender: differences in methamphetamine neurotoxicity Ann. N.Y. Acad. Sci. 965 2002 136 156
15. D.E. Dluzen, J.L. McDermott, and B. Liu Estrogen as a neuroprotectant against MPTP-induced neurotoxicity in C57/Bl mice Neurotoxicol. Teratol. 18 1996 603 606
16. D.E. Dluzen, J.L. McDermott, and L.I. Anderson Tamoxifen eliminates estrogen's neuroprotective effect upon MPTP-induced neurotoxicity of the nigrostriatal dopaminergic system Neurotox. Res. 3 2001 291 300
17. D.E. Dluzen, J.L. McDermott, and L.I. Anderson Tamoxifen diminishes methamphetamine-induced striatal dopamine depletion in intact female and male mice J. Neuroendocrinol. 13 2001 618 624
18. M.L. Dodds, M.E. Kargacin, and G.J. Kargacin Effects of anti-oestrogens and beta-estradiol on calcium uptake by cardiac sarcoplasmic reticulum Br. J. Pharmacol. 132 2001 1374 1382
19. X. Gao, and D.E. Dluzen Tamoxifen abolishes estrogen's neuroprotective effects upon methamphetamine neurotoxicity of the nigrostriatal dopaminergic system Neuroscience 103 2001 385 394
20. X. Gao, and D.E. Dluzen The effect of testosterone upon methamphetamine neurotoxicity of the nigrostriatal dopaminergic system Brain Res. 892 2001 63 69
21. G.E. Gillies, H.E. Murray, D. Dexter, and S. McArthur Sex dimorphisms in the neuroprotective effects of estrogen in an animal model of Parkinson's disease Pharmacol. Biochem. Behav. 78 2004 513 522
22. M. Grandbois, M. Morissette, M. Callier, and T. Di Paolo Ovarian steroids and raloxifene prevent MPTP-induced dopamine depletion in mice NeuroReport 11 2000 343 346
23. E. Gursoy, A. Cardounel, T. Al-khlaiwi, A. Al-drees, and M. Kalimi Tamoxifen protects clonal mouse hippocampal (HT-22) cells against neurotoxin-induced cell death Neurochem. Int. 40 2002 405 412
24. C. Hiemke, and R. Ghraf Interaction of non-steroidal anti-estrogens with dopamine binding J. Steroid Biochem. 14 1984 421 472
25. K.R. Hoyt, B.A. McLaughlin, D.S. Higgins Jr., and I.J. Reynolds Inhibition of glutamate-induced mitochondrial depolarization by tamoxifen in cultured neurons J. Pharmacol. Exp. Ther. 293 2000 480 486
26. S.J. Hutchinson, T.M. Chou, K. Chatterjee, and K. Sudhir Tamoxifen is an acute, estrogen-like, coronary vasodilator of porcine coronary arteries in vitro J. Cardiovasc. Pharmacol. 38 2001 657 665
27. H.K. Kimelberg, P.J. Feustel, Y. Jin, J. Paquette, A. Boulos, R.W. Keller Jr., and B.I. Tranmer Acute treatment with tamoxifen reduces ischemic damage following cerebral artery occlusion NeuroReport 11 2000 2675 2679
28. H.K. Kimelberg, Y. Jin, C. Charniga, and P.J. Feustel Neuroprotective activity of tamoxifen in permanent focal ischemia J. Neurosurg. 99 2003 138 142
29. J.L. McDermott, B. Liu, and D.E. Dluzen Tamoxifen treatment of ovariectomized mice alters dopamine release from striatal tissue fragments superfused in vitro Brain Res. 698 1995 248 252
30. J.L. McDermott, L.I. Anderson, and D.E. Dluzen Interactive effects of tamoxifen and estrogen upon the nigrostriatal dopaminergic system Neuroendocrinology 66 1997 181 187
31. J.L. McDermott, L.I. Anderson, and D.E. Dluzen Tamoxifen alters dopamine output through direct actions upon superfused corpus striatal tissue fragments Neurochem. Int. 32 1998 299 307
32. J.L. McDermott, L.I. Anderson, and D.E. Dluzen Interactive effects of tamoxifen and oestrogen upon the nigrostriatal dopaminergic system: long-term treatments J. Neuroendocrinol. 11 1999 801 803
33. B.S. McEwen, and S.E. Alves Estrogen actions in the central nervous system Endocr. Rev. 20 1999 279 307
34. B.S. McEwen, H. Coirini, and M. Schumacher Steroid effect on neuronal activity: when is the genome involved? Ciba Fdn. Ser.-Steroids and Neuronal Activity 153 1990 3 21
35. R.E. Myers, L.I. Anderson, and D.E. Dluzen Estrogen, but not testosterone, attenuates methamphetamine-evoked dopamine output from superfused striatal tissue of female and male mice Neuropharmacology 44 2003 624 632
36. T. Obata, and S. Kubota Protective effect of tamoxifen on 1-methyl-4-phenylpyridine-induced hydroxyl radical generation in the rat striatum Neurosci. Lett. 308 2001 87 90
37. C.A. O'Brien, R.M. Liskamp, D.H. Solomon, and I.B. Weinstein Inhibition of protein kinase C by tamoxifen Cancer Res. 45 1985 2462 2465
38. K. Osuka, P.J. Feustel, A.A. Mongin, B.I. Tranmer, and H.K. Kimelberg Tamoxifen inhibits nitrotyrosine formation after reversible middle cerebral artery occlusion in the rat J. Neurochem. 76 2001 1842 1850
39. D. Pfaff, and M. Keiner Atlas of estradiol-concentrating cells in the central nervous system of the rat Comp. Neurol. 151 1973 121 158
40. J.W. Phillis, D. Song, and M.H. O'Regan Tamoxifen, a chloride channel blocker, reduces glutamate and aspartate release from the ischemic cerebral cortex Brain Res. 780 1998 352 355
41. V.D. Ramirez, K. Kim, and D.E. Dluzen Progesterone action on the LHRH and nigrostriatal dopamine neuronal systems: in vitro and in vivo studies Rec. Prog. Horm. Res. 41 1985 421 472
42. M. Sato, M.K. Rippy, and U. Bryant Raloxifene, tamoxifen, nafoxidine or estrogen effects on reproductive and nonreproductive tissues in ovariectomized rats FASEB J. 10 1996 905 912
43. F. Severcan, N. Kazanci, and F. Zorlu Tamoxifen increases membrane fluidity at high concentrations Biosci. Rep. 20 2000 177 184
44. H. Shy, L. Malaiyandi, and P. Timiras Protective action of 17beta-estradiol and tamoxifen on glutamate toxicity in glial cells Int. J. Dev. Neurosci. 18 2000 289 297
45. + currents by tamoxifen J. Membr. Biol. 181 2001 125 133
46. J. Song, P.R. Standley, F. Zhang, D. Joshi, S. Gappy, J.R. Sowers, and J.L. Ram Tamoxifen (estrogen antagonist) inhibits voltage-gated calcium current and contractility in vascular smooth muscle from rats J. Pharmacol. Exp. Ther. 277 1996 1444 1453
47. T.W. Toney, and B.S. Katzenellenbogen An evaluation of the interactions of antiestrogens with pituitary and striatal dopamine receptors J. Recept. Res. 7 1987 695 712
48. H. Wiseman Tamoxifen as an antioxidant and cardioprotectant Biochem. Soc. Symp. 61 1995 209 219
49. L. Xiao, L.R. Jackson, and J.B. Becker The effect of estradiol in the striatum is blocked by ICI 182,780 but not tamoxifen: pharmacological and behavioral evidence Neuroendocrinology 77 2003 239 245
50. L. Yu, Y. Kuo, C.G. Cherng, H.-H. Chen, and C.-H. Hsu Ovarian hormones do not attenuate methamphetamine-induced dopaminergic neurotoxicity in mice gonadectomized at 4 weeks post-partum Neuroendocrinology 75 2002 282 287